Farewell, Swabs? How a New COVID Breath Test Gives Results in 3 Minutes
A newly authorized breathalyzer test examines exhalations to quickly detect the presence of COVID-19. Learn how it works.
On Thursday, the US Food and Drug Administration authorized emergency use of the Inspectir COVID-19 Breathalyzer — a diagnostic test that uses your breath, rather than a nasal swab sample, to detect the presence of the virus. The test kit, which is roughly the size of a small suitcase, searches for chemical compounds that are found in the exhalations of people infected with COVID.
InspectIR is promoting the test as both less invasive and faster than PCR or even rapid antigen tests, making it potentially useful for public settings like offices, restaurants and airports.
In the FDA announcement of the emergency authorization, Dr. Jeff Shuren, director of the agency’s Center for Devices and Radiological Health, called the device “another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
Read on to learn how the Inspectir COVID-19 Breathalyzer, where it could be used and how it compares to PCD and rapid antigen tests. For more, learn how to order more free at-home COVID tests from the government and everything we know about the BA.2 subvariant and long COVID.
We are excited about the future of work…and know that InspectIR and our instrument can help alleviate some of your fears. If you are interested in learning more, please call 469.206.4555 or write firstname.lastname@example.org